This paper compared the DNA yield from serum when extraction was with seven different methods and quantified using fluorometry, real-time PCR, and real-time PCR after bisulfite conversion. The size of isolated DNA was also compared by electrophoresis.
Comparison of 7 methods for extracting cell-free DNA from serum samples of colorectal cancer patients.
Fong SL, Zhang JT, Lim CK, Eu KW, Liu Y
Purpose
Conclusion
The DNA concentration as measured by fluorometry and amplification of CDH1 was highest when extraction was with the phenol/chloroform method with addition of glycogen or an in-house sodium iodide-based method followed by the QIAamp DNA Blood Midi Kit with carrier RNA. Importantly, these three methods were the only methods that yielded sufficient DNA to amplify ACTB after bisulfite conversion. While not significantly different from the phenol/chloroform method, the sodium iodide-based method yielded more amplifiable DNA overall and after bisulfite conversion. Electrophoresis revealed visible bands of 200, 400, and 500 bp when extracted using the phenol/chloroform method with addition of glycogen or an in-house sodium iodide-based method but only the 500 bp band was visible when extraction was with the other methods. The authors state the loss of 200 and 400 bp bands indicated poor recovery of nucleosomal DNA.
Studies (1)
Purpose
This study compared the DNA yield from serum when extraction was with seven different methods and quantified using fluorometry, real-time PCR, and real-time PCR after bisulfite conversion. The size of isolated DNA was also compared by electrophoresis. Twelve pooled serum specimens were obtained from the serum of 67 patients with colorectal carcinoma (details of blood procurement and processing not provided). Serum is assumed to have been frozen prior to use. DNA was extracted from serum using a phenol/chloroform method with addition of glycogen, an in-house sodium iodide method, an in-house guanidine-resin based method, the QIAamp DNA Blood Midi Kit with carrier RNA, the ChargeSwitch 1-mL Serum Kit, the Zymo Research Serum DNA Kit, or the Puregene DNA Purification System Cell and Tissue Kit. DNA was quantified by Quant-iT dsDNA HS assay (Invitrogen) and by real-time PCR amplification of the epithelial cadherin 1(CDH1) gene. DNA was also bisulfite-converted and quantified by amplification of a region of ACTB without CpG sites. The size distribution of DNA was investigated by electrophoresis of DNA isolated from 1 mL of serum.
Summary of Findings
The DNA concentration as measured by fluorometry and amplification of CDH1 was highest when extraction was with the phenol/chloroform method with addition of glycogen or an in-house sodium iodide-based method followed by the QIAamp DNA Blood Midi Kit with carrier RNA. Importantly, these three methods were the only methods that yielded sufficient DNA to amplify ACTB after bisulfite conversion. Electrophoresis revealed visible bands of 200, 400, and 500 bp when extraction was with the phenol/chloroform based method with addition of glycogen or the in-house sodium iodide-based method but only the 500 bp band was visible when extraction was with the other methods. The authors state the loss of 200 and 400 bp bands indicated poor recovery of nucleosomal DNA. While not significantly different from the phenol-chloroform based method, the sodium iodide-based method yielded more amplifiable DNA overall and at a lower cost after bisulfite conversion, making it the authors method of choice.
Biospecimens
FluidSerumPreservation Types
FrozenDiagnoses
NeoplasticCarcinomaPlatforms
DNAFluorometryDNABisulfite conversion assayDNAReal-time qPCRDNAElectrophoresisPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Analyte Extraction and Purification Analyte isolation method ChargeSwitch 1-mL Serum KitIn-house guanidine-resin based methodIn-house sodium iodide methodPhenol/chloroform method with addition of glycogenPuregene DNA Purification System Cell and Tissue KitQIAamp DNA Blood Midi Kit with carrier RNAZymo Research Serum DNA KitBisulfite conversion assay Specific Targeted nucleic acid ACTBReal-time qPCR Specific Targeted nucleic acid CDH1Real-time qPCR Specific Technology platform Amplification of bisulfite converted DNAFluorometryStandard real-time PCR